Evidence map›Paper›PMID 26202308›Full record

ArticleMuscle & nerve2015

Increased frequency of rhabdomyolysis in familial dysautonomia.

Jose-Alberto Palma, Ricardo Roda, Lucy Norcliffe-Kaufmann, Horacio Kaufmann

Open access · greenAbstract read
In one paragraph

Article in Muscle & nerve, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Animal and cellular models of familial dysautonomia.Clinical autonomic research : official journal of the Clinical Autonomic Research Society · 2017
    Review
  3. BGP-15 prevents the death of neurons in a mouse model of familial dysautonomia.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  4. Pathological Confirmation of Optic Neuropathy in Familial Dysautonomia.Journal of neuropathology and experimental neurology · 2017
    Article
  5. Dexmedetomidine for refractory adrenergic crisis in familial dysautonomia.Clinical autonomic research : official journal of the Clinical Autonomic Research Society · 2017
    Article
  6. Current treatments in familial dysautonomia.Expert opinion on pharmacotherapy · 2014
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Jose-Alberto PalmaDysautonomia Center, Department of Neurology, New York University School of Medicine, 530 First Avenue, Suite 9Q, New York, New York, 10016, USA.
Ricardo RodaNeuromuscular Division, Department of Neurology, New York University School of Medicine, New York, New York, USA.
Lucy Norcliffe-KaufmannDysautonomia Center, Department of Neurology, New York University School of Medicine, 530 First Avenue, Suite 9Q, New York, New York, 10016, USA.
Horacio KaufmannDysautonomia Center, Department of Neurology, New York University School of Medicine, 530 First Avenue, Suite 9Q, New York, New York, 10016, USA.
Dysautonomia Foundation · USNew York University · US

Funding

Training CoreU54NS065736 · NINDS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI LOW, PHILLIP A · 2009 to 2018
$11.6M
Optimization of compounds to improve mRNA splicing in familial dysautonomiaU01NS078025 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI SLAUGENHAUPT, SUSAN A · 2012 to 2016
$1.3M
NINDS NIH HHS 1U01NS078025-01NINDS NIH HHS U01 NS078025NINDS NIH HHS U54 NS065736NINDS NIH HHS U54NS065736
6 · The paper itself

Abstract

introductionFamilial dysautonomia (FD; OMIM # 223900) is an autosomal recessive disease with features of impaired pain and temperature perception and lack of functional muscle spindles. After 3 FD patients presented with rhabdomyolysis in a short time span, we aimed to determine the frequency of rhabdomyolysis is this population.

methodsThis study was a retrospective chart review of 665 FD patients.

resultsEight patients had at least 1 episode of rhabdomyolysis. Two patients had 2 episodes. The average incidence of rhabdomyolysis in FD was 7.5 per 10,000 person-years. By comparison, the average incidence with statins has been reported to be 0.44 per 10,000 person-years. Mean maximum creatine kinase (CK) level was 32,714 ± 64,749 U/L. Three patients had hip magnetic resonance imaging showing gluteal hyperintensities.

conclusionsPatients with FD have an increased incidence of rhabdomyolysis. We hypothesize that this may result from a combination of absent functional muscle spindles and muscle mitochondrial abnormalities.

Indexed as

AdolescentChildDysautonomia, FamilialFemaleFollow-Up StudiesHumansMaleRetrospective StudiesRhabdomyolysisYoung Adultautonomic disorderscreatine kinasehereditary sensory autonomic neuropathymitochondriaskeletal muscle

Identifiers

PMID26202308
PMCPMC4596763
OpenAlexW1554279120

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.